Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection-Reference-Cited by-同舟云学术

Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection

Published:2016-06-03 Issue:6 Volume:11 Page:e0156667
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Al-Mahtab Mamun,Bazinet Michel,Vaillant Andrew

Funder

Replicor Inc.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;A Scheitzer;The Lancet,2015

2. Hepatitis B virus infection-natural history and clinical consequences;D Ganem;N. Engl. J. Med,2004

3. Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients;R Moucari;Hepatology,2009

4. To “Be” or not to “Be”: That is the question;CT Frenette;Am. J. Gastroenterol,2009

5. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B;P Marcellin;N Engl J Med,2004

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of a Hepatitis B Virus Reporter System Harboring an HiBiT-Tag in the PreS2 Region;The Journal of Infectious Diseases;2024-07-11

2. Current trends and advances in antiviral therapy for chronic hepatitis B;Chinese Medical Journal;2024-06-28

3. An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patients;Antiviral Research;2024-04

4. Longterm Outcome of Therapeutic Vaccination with a Third Generation Pre-S/S HBV Vaccine (PreHevbrioR) of Chronically HBV Infected Patients;Journal of Personalized Medicine;2024-03-29

5. A revolutionary oral HBV treatment candidate as innovative therapeutic approach warranting clinical trials;Journal of Gastroenterology;2024-03-25